IPO Announced

Kailera Therapeutics IPO

US$625m raised

Lodged 16 Apr 2026 · NASDAQ: KLRA

Advisers

Kailera Therapeutics

Issuer

Financial adviser
Legal adviser

Lead managers

Lead manager
Legal adviser
Issuer
Kailera Therapeutics
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.